Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7,936,508
-
Total 13F shares
-
1,148,993
-
Share change
-
+1,148,993
-
Total reported value
-
$8,674,797
-
Price per share
-
$7.55
-
Number of holders
-
25
-
Value change
-
+$8,674,797
-
Number of buys
-
25
Institutional Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q3 2025
As of 30 Sep 2025,
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,148,993 shares.
The largest 10 holders included
Telemark Asset Management, LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Monashee Investment Management LLC, PERKINS CAPITAL MANAGEMENT INC, SILVERARC CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, Balyasny Asset Management L.P., GEODE CAPITAL MANAGEMENT, LLC, and BlackRock, Inc..
This page lists
25
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.